Autolus Therapeutics is a leader in T cell programming, focused on the development of targeted, controlled, and highly active T cell therapies which offer substantial benefits over existing standards of care. As they prepared to list on NASDAQ, they realised they needed a stronger platform for their new website. They challenged us to build a modular solution that would grow with them, with additional custom elements to reinforce their brand.
How we helped
We built an intuitive CMS for key news and content updates.
Working with partners in different time zones, we delivered IPO content and feeds.
We enhanced Autolus’ photo library and created graphics explaining the business.
We provide ongoing support, regularly reviewing design, content and structure.
“Working with Design Portfolio on the Autolus website has been straightforward and stress free. We have full control of the website to make updates and multiple members of the team can change pages of the site with little guidance or additional support. The CMS is intuitive and allows us to grow the website as the business grows.”
Julia Wilson – International Media Contact,
Autolus is happy to have complete control of information available on their website through the secure Content Management System we built for them. This CMS platform allows editors to quickly and easily update content, job descriptions, news, and more, with integrated NASDAQ tools providing share price data and announcements. This makes it easy to provide up to the minute information in an engaging format to Autolus stakeholders around the globe.